Shattuck Labs (STTK) Shares Outstanding (2019 - 2026)
Shattuck Labs (STTK) reported Shares Outstanding of $75.6 million for Q1 2026, up 57.79% year-over-year from $47.9 million in Q1 2025, and up 19.44% quarter-over-quarter from $63.3 million in Q4 2025.
Shattuck Labs (STTK) Shares Outstanding (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Shares Outstanding data on file, last reported at $75.6 million in Q1 2026.
- Shares Outstanding for Q1 2026 came in at $75.6 million, up 57.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.6 million (up 57.79% YoY), and the FY2025 annual result was $63.3 million, up 32.62% from the prior year.
- Shares Outstanding improved to $75.6 million in Q1 2026 per STTK's latest filing, from $63.3 million in the prior quarter.
- Over five years, Shares Outstanding peaked at $75.6 million in Q1 2026 and troughed at $42.4 million in Q1 2022.
- A 5-year average of $49.0 million and a median of $47.5 million in 2024 frame the typical range for Shares Outstanding.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding advanced 0.12% in 2022, then surged 57.79% in 2026.
- A 5-year view of Shares Outstanding shows it stood at $42.4 million in 2022, then rose by 11.49% to $47.3 million in 2023, then gained by 0.96% to $47.7 million in 2024, then soared by 32.62% to $63.3 million in 2025, then rose by 19.44% to $75.6 million in 2026.
- Business Quant data shows STTK's Shares Outstanding at $75.6 million in Q1 2026, $63.3 million in Q4 2025, and $63.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 75.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.58 Mn |
| Mar 31, 2026 | 75.58 Mn |
| Mar 31, 2026 | 75.58 Mn |
| Mar 31, 2026 | 75.58 Mn |
| Mar 31, 2026 | 75.58 Mn |
| Mar 31, 2026 | 75.58 Mn |
| Mar 31, 2026 | 75.58 Mn |
| Mar 31, 2026 | 75.58 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Dec 31, 2025 | 63.28 Mn |
| Sep 30, 2025 | 63.15 Mn |
| Sep 30, 2025 | 63.15 Mn |
| Sep 30, 2025 | 63.15 Mn |
| Sep 30, 2025 | 63.15 Mn |